These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 4695207)

  • 21. [Role of central catecholamines in the psychostimulant activity of pyrovalerone].
    Fauquet JP; Morel E; Demarty C; Rapin JR
    Arch Int Pharmacodyn Ther; 1976 Dec; 224(2):325-37. PubMed ID: 1035081
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differences in the locomotor activity of mice as measured by an Animex and photoresis to actometer.
    Maj J; Durek B; Palider W
    J Pharm Pharmacol; 1971 Dec; 23(12):979-81. PubMed ID: 4402032
    [No Abstract]   [Full Text] [Related]  

  • 23. "Paradoxical" stereotyped activity of reserpinized rats.
    Schiorring E; Randrup A
    Int J Neuropharmacol; 1968 Jan; 7(1):71-3. PubMed ID: 5639310
    [No Abstract]   [Full Text] [Related]  

  • 24. Some aspects of the mechanism of action of various stimulant amphetamine analogues.
    Scheel-Krüger J
    Psychiatr Neurol Neurochir; 1972; 75(3):179-92. PubMed ID: 4402652
    [No Abstract]   [Full Text] [Related]  

  • 25. The relationship between the inhibition of dopamine uptake and the enhancement of amphetamine stereotypy.
    Naylor RJ; Costall B
    Life Sci I; 1971 Aug; 10(16):909-15. PubMed ID: 4398323
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of lithium on behaviour and central monoamines.
    Engel J; Berggren U
    Acta Psychiatr Scand Suppl; 1980; 280():133-43. PubMed ID: 6773300
    [No Abstract]   [Full Text] [Related]  

  • 27. Role of catecholamines in the central effects of amphetamine.
    Pfeifer AK; György L; Fodor M
    Acta Med Acad Sci Hung; 1968; 25(3):441-50. PubMed ID: 5720870
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of amantadine on the rate of dopamine synthesis in rat corpus striatum.
    Bariletto S; Dollar E; Leitz F
    J Neurochem; 1975 Aug; 25(2):139-42. PubMed ID: 1141911
    [No Abstract]   [Full Text] [Related]  

  • 29. Time-related interaction patterns of amphetamine with reserpine and other central depressants.
    Banerjee U; Geh SL
    Res Commun Chem Pathol Pharmacol; 1973 Jul; 6(1):109-22. PubMed ID: 4739077
    [No Abstract]   [Full Text] [Related]  

  • 30. Evidence for presynaptic dopamine mechanisms underlying amphetamine-conditioned locomotion.
    DiLullo SL; Martin-Iverson MT
    Brain Res; 1992 Apr; 578(1-2):161-7. PubMed ID: 1354997
    [TBL] [Abstract][Full Text] [Related]  

  • 31. "Designer" amphetamines: effects on behavior and monoamines with or without reserpine and/or alpha-methyl-para-tyrosine pretreatment.
    Martin-Iverson MT; Yamada N; By AW; Lodge BA
    J Psychiatry Neurosci; 1991 Dec; 16(5):253-61. PubMed ID: 1686728
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Behavioural supersensitivity to apomorphine following chronic treatment with drugs which interfere with the synaptic function of catecholamines.
    Tarsy D; Baldessarini RJ
    Neuropharmacology; 1974 Nov; 13(10-11):927-40. PubMed ID: 4474641
    [No Abstract]   [Full Text] [Related]  

  • 33. A comparison of the locomotor stimulant properties of amantadine and l- and d-amphetamine in mice.
    Thornburg JE; Moore KE
    Neuropharmacology; 1972 Sep; 11(5):675-82. PubMed ID: 4151250
    [No Abstract]   [Full Text] [Related]  

  • 34. Diurnal rhythm in behavioral effects of methamphetamine, p-chloramethamphetamine and scopolamine.
    Evans HL; Ghiselli WB; Patton RA
    J Pharmacol Exp Ther; 1973 Jul; 186(1):10-7. PubMed ID: 4723307
    [No Abstract]   [Full Text] [Related]  

  • 35. [Interaction of sydnocarb with preparations influencing the metabolism of catecholamines].
    Al'tshuler RA; Roshchina LF; Mashkovskiĭ MD
    Farmakol Toksikol; 1976; 39(1):9-14. PubMed ID: 943326
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of ECT on dopaminergic and noradrenergic mechanisms. I. Effect on the behavioural changes induced by reserpine, alpha-methyl-p-tyrosine or amphetamine.
    Papeschi R; Randrup A; Lai S
    Psychopharmacologia; 1974 Feb; 35(2):149-58. PubMed ID: 4856059
    [No Abstract]   [Full Text] [Related]  

  • 37. Mode of action of psychomotor stimulant drugs.
    Van Rossum JM
    Int Rev Neurobiol; 1970; 12():307-83. PubMed ID: 4918147
    [No Abstract]   [Full Text] [Related]  

  • 38. Amphetamine and 5-hydroxytryptamine inhibition of copulatory behaviour in the female rat.
    Meyerson BJ
    Ann Med Exp Biol Fenn; 1968; 46(3):394-8. PubMed ID: 5734243
    [No Abstract]   [Full Text] [Related]  

  • 39. Significance of dopamine receptor activity in dl-p-methoxyamphetamine- and d-amphetamine-induced locomotor activity.
    Tseng LF; Loh HH
    J Pharmacol Exp Ther; 1974 Jun; 189(3):717-24. PubMed ID: 4858403
    [No Abstract]   [Full Text] [Related]  

  • 40. On the mode of action of amantadine.
    Stromberg U; Svensson TH; Waldeck B
    J Pharm Pharmacol; 1970 Dec; 22(12):959-62. PubMed ID: 4395528
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.